The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).
B02BB - Fibrinogen
Preparations containing human fibrinogen for systemic use are classified here. B02BB01 is reserved for systemic formulations only.
